ZA92510B - Vaccine composition against influenza,with synergic effects,containing influenza virus core as an additive - Google Patents

Vaccine composition against influenza,with synergic effects,containing influenza virus core as an additive

Info

Publication number
ZA92510B
ZA92510B ZA92510A ZA92510A ZA92510B ZA 92510 B ZA92510 B ZA 92510B ZA 92510 A ZA92510 A ZA 92510A ZA 92510 A ZA92510 A ZA 92510A ZA 92510 B ZA92510 B ZA 92510B
Authority
ZA
South Africa
Prior art keywords
additive
vaccine composition
influenza virus
composition against
virus core
Prior art date
Application number
ZA92510A
Other languages
English (en)
Inventor
Catherine Moste-Deshairs
Moste-Deshairs Catherine
Bernard Meignier
Meignier Bernard
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9409015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA92510(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of ZA92510B publication Critical patent/ZA92510B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA92510A 1991-01-24 1992-01-24 Vaccine composition against influenza,with synergic effects,containing influenza virus core as an additive ZA92510B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9100806A FR2671974A1 (fr) 1991-01-24 1991-01-24 Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.

Publications (1)

Publication Number Publication Date
ZA92510B true ZA92510B (en) 1992-11-25

Family

ID=9409015

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92510A ZA92510B (en) 1991-01-24 1992-01-24 Vaccine composition against influenza,with synergic effects,containing influenza virus core as an additive

Country Status (10)

Country Link
EP (1) EP0522138B2 (enrdf_load_stackoverflow)
AT (1) ATE234861T1 (enrdf_load_stackoverflow)
AU (1) AU654699B2 (enrdf_load_stackoverflow)
CA (1) CA2078985C (enrdf_load_stackoverflow)
DE (1) DE69232962T3 (enrdf_load_stackoverflow)
FR (1) FR2671974A1 (enrdf_load_stackoverflow)
IL (1) IL100765A (enrdf_load_stackoverflow)
NZ (1) NZ241398A (enrdf_load_stackoverflow)
WO (1) WO1992013002A1 (enrdf_load_stackoverflow)
ZA (1) ZA92510B (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994019013A1 (en) * 1993-02-19 1994-09-01 Smithkline Beecham Corporation Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
WO1998046262A1 (en) * 1997-04-16 1998-10-22 Connaught Laboratories, Inc. Anti-influenza compositions supplemented with neuraminidase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
GB8502096D0 (en) * 1985-01-28 1985-02-27 Medical Res Council Influenza vaccine
US5136019A (en) * 1989-05-24 1992-08-04 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use

Also Published As

Publication number Publication date
DE69232962T2 (de) 2005-06-23
EP0522138B1 (fr) 2003-03-19
IL100765A (en) 1996-06-18
AU654699B2 (en) 1994-11-17
DE69232962T3 (de) 2007-11-08
CA2078985C (fr) 2004-11-09
FR2671974A1 (fr) 1992-07-31
AU1248792A (en) 1992-08-27
NZ241398A (en) 1994-08-26
WO1992013002A1 (fr) 1992-08-06
CA2078985A1 (fr) 1992-07-25
EP0522138A1 (fr) 1993-01-13
IL100765A0 (en) 1992-09-06
FR2671974B1 (enrdf_load_stackoverflow) 1995-03-03
DE69232962D1 (de) 2003-04-24
ATE234861T1 (de) 2003-04-15
EP0522138B2 (fr) 2007-02-14

Similar Documents

Publication Publication Date Title
MY104685A (en) Substituted thiazoles and their use as fungicides.
EP0568035A3 (en) Cosmetic agent formulated with an aqueous polymer emulsion.
IL96458A0 (en) Isoxazolines,their preparation,and their use as plantprotecting agents
NO944377D0 (no) Kjölemiddelblandinger
MY109233A (en) Compositions useful in the manufacture of golfballs
DK0608912T3 (da) Synergistiske mikrobicide sammensætninger
EP0599532A3 (en) One-component crosslinkable organosiloxane compositions.
EP0640097A4 (en) COMPOSITION AND METHODS FOR VACCINATING AGAINST CORONAVIRES (01/20/94).
DE69202822D1 (de) Silikonmodifizierte wässrige Überzugszusammensetzung.
AP9400621A0 (en) Influenza vaccine compositions
ES2058346T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
ATE88087T1 (de) Chitosan enthaltendes kosmetisches praeparat.
EA199900069A1 (ru) Вакцинная композиция против малярии
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
IL116010A0 (en) Immunogenic compositions
EP1666057A3 (en) An acellular vaccine comprising Bordetella pertussis antigens
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
ZA92510B (en) Vaccine composition against influenza,with synergic effects,containing influenza virus core as an additive
FI893721A0 (fi) Synergistisk soetningskomposition och preparat innehaollande densamma.
AU1485192A (en) Crop-protecting compositions containing isoxazolines or isothiazolines, novel isoxazolines and isothiazolines, and their preparation
NZ226677A (en) Avian vaccine and composition against e.coli
ZA911385B (en) The use of hexamethylenetetramine as a stabilizer for 3-isothiazolones
ZA902245B (en) Azolylethylcyclopropanes,the preparation thereof and the use thereof as crop protection agents
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.